Research

Hormonal

Exogenous ghrelin infusion suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans in a dose-dependent manner.

This research indicates that higher levels of the hormone ghrelin directly reduce the body's ability to secrete insulin in response to glucose, leading to worse glucose tolerance. For healthy individuals, this suggests that conditions or interventions that significantly elevate ghrelin (like prolonged fasting or specific pharmacological agents) might impair glucose handling. It does not suggest using ghrelin as a treatment, but rather highlights it as a factor to consider in metabolic health.

GoodSupportsHIGH confidence
This is a robust proof-of-concept study showing that exogenous ghrelin reduces glucose-stimulated insulin secretion and glucose disappearance in healthy humans.
Jenny Tong et al. · Diabetes · 2010

Why this rating

Randomized, counterbalanced, controlled human trial with robust statistical analysis, though limited to healthy subjects and short duration.

Source

Ghrelin Suppresses Glucose-Stimulated Insulin Secretion and Deteriorates Glucose Tolerance in Healthy Humans

Jenny Tong et al. · Diabetes · 2010

DOI 10.2337/db10-0504

rct · n=12Cited 322×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →